-
Mashup Score: 4
JAB-8263 given at once-daily doses ranging from 0.125 mg to 0.3 mg proved to be well tolerated in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
JAB-8263 given at once-daily doses ranging from 0.125 mg to 0.3 mg proved to be well tolerated in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
JAB-8263 Monotherapy Demonstrates Early Promise in Myelofibrosis @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/4fDQqEyL2J
-
-
Mashup Score: 0NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET - 9 day(s) ago
NFKB1 rs230511 reduces inflammation and amplifies responses to ropeginterferon alfa-2b in polycythemia vera and essential thrombocythemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET @huntsmancancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/11urXN6OXF
-
-
Mashup Score: 0NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET - 11 day(s) ago
NFKB1 rs230511 reduces inflammation and amplifies responses to ropeginterferon alfa-2b in polycythemia vera and essential thrombocythemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET @huntsmancancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/11urXN6OXF
-
-
Mashup Score: 0NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET - 17 day(s) ago
NFKB1 rs230511 reduces inflammation and amplifies responses to ropeginterferon alfa-2b in polycythemia vera and essential thrombocythemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET @huntsmancancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/11urXN6OXF
-
-
Mashup Score: 0NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET - 19 day(s) ago
NFKB1 rs230511 reduces inflammation and amplifies responses to ropeginterferon alfa-2b in polycythemia vera and essential thrombocythemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET @huntsmancancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/11urXN6OXF
-
-
Mashup Score: 5
Findings showed the potential impact of smoking on disease progression and survival in patients with myelodysplastic syndrome.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Smoking May Increase Genetic Mutations, Disease Progression in MDS @drsangeetmd @SylvesterCancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/zIZSRsrSYE
-
-
Mashup Score: 5
Findings showed the potential impact of smoking on disease progression and survival in patients with myelodysplastic syndrome.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Smoking May Increase Genetic Mutations, Disease Progression in MDS @drsangeetmd @SylvesterCancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/zIZSRsrSYE
-
-
Mashup Score: 3JAB-8263 Monotherapy Demonstrates Early Promise in Myelofibrosis - 25 day(s) ago
JAB-8263 given at once-daily doses ranging from 0.125 mg to 0.3 mg proved to be well tolerated in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
JAB-8263 Monotherapy Demonstrates Early Promise in Myelofibrosis @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/4fDQqEyL2J
-
-
Mashup Score: 0NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET - 28 day(s) ago
NFKB1 rs230511 reduces inflammation and amplifies responses to ropeginterferon alfa-2b in polycythemia vera and essential thrombocythemia.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
NFKB1 Haplotype Decreases Inflammation, Increases Response to Ropeginterferon Alfa-2b in PV and ET @huntsmancancer @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/11urXN6OXF
-
JAB-8263 Monotherapy Demonstrates Early Promise in Myelofibrosis @ASH_hematology #ASH24 #medtwitter #oncology https://t.co/4fDQqEyL2J